Sociedad Española de Terapia Génica y Celular
  • Home
  • About us
    • About us
    • History
    • Board Information
    • Awards
      • Award winners
    • Legal & bylaws
  • Events
    • Events
    • Sponsorship
    • Ask-the-expert
    • Current congress
    • e-School
    • e-Seminars
    • Previous Events
    • Upcoming events
    • Frequently asked questions
  • Networking & community
    • Networking & community
    • Gene and cell therapy community heatmap
    • Introduction to the Forum
    • Latest news
    • Non ESGCT events
    • Jobs & Courses
    • Blog
    • Newsletter archive
    • National Gene and cell therapy societies
  • Policies & advocacy
    • Policies & advocacy
    • Regulatory information
      • GMP Guidelines
    • EMA guidance
    • ESGCT statements
    • Useful links
  • Public & Patients
    • Public & Patients
    • Gene and cell therapy education
      • Covid 19 vaccines
      • Gene therapy 101
        • Cell therapy basics
        • Different approaches
        • Gene therapy basics
        • Vectors 101
    • Patients perspective
    • Sites of interest
    • What is gene therapy
  • Membership
    • Membership
    • Become a member
    • General Assembly of Members
    • Human Gene Therapy
    • Membership benefits
Home

This week in gene and cell therapy - 12 April 2019

Gene and cell therapy headlines 8 - 12 April


FDA Places Gene Therapy AMT-130 on Fast Track to Speed Development

'Dismantling cancer' reveals weak spots

New Kind of Cancer 'Vaccine' Teaches The Immune System to Destroy Tumours

Scientists use CRISPR for possible 'bubble boy' therapy

New CRISPR Tool Described as a DNA Shredder with a Motor
 

Account login

Create a secure accountJoin
Forgotten your details?

Sponsors

Diamond

Platinum

Gold

Silver

Bronze

Copyright © 2022 Sociedad Española de Terapia Génica y Celular Member Area Terms and Conditions user account Privacy Policy Cookies Terms and Conditions membership purchase Terms and Conditions congress registration Terms and Conditions abstract submission Terms and Conditions user account RSS feed Join us Follow us